Quest PharmaTech Inc.
QPT.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 123.60K | 104.40K | 87.10K | 37.30K | 235.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 195.00K | 179.70K | 131.20K | 84.90K | 261.10K |
| Operating Income | -195.00K | -179.70K | -131.20K | -84.90K | -261.10K |
| Income Before Tax | -1.19M | 25.40K | 525.50K | -634.80K | -1.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.19M | 25.40K | 525.50K | -634.80K | -1.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.19M | 25.40K | 525.50K | -634.80K | -1.47M |
| EBIT | -195.00K | -179.70K | -131.20K | -84.90K | -261.10K |
| EBITDA | -194.50K | -179.10K | -130.70K | -84.30K | -261.10K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Average Diluted Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |